Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Medicare Advantage Special Needs Plans now make up more than a quarter of all enrollments. Learn more about what they are and ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

Eknath Chavan, a 62-year-old man from Mumbai, celebrates his diabetes remission after 18 years, fitting into his wedding suit ...